Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-003619-23Phase 4Terminated
Phase 4, randomised trial of Medivitan in vitamin B12 deficiency (2 arms), sponsored by Medice. Primary endpoint: Serum vitamin B12 concentration. Started Oct 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-003619-23.